Non-Massachusetts certified Emergency Medical Technicians (EMTs) must be nationally certified and receive verification from your home state to apply for a Massachusetts EMT license.

The National Registry of Emergency Medical Technicians® (NREMT) website contains information and outlines the application process for EMT national certification. The NREMT website can also help to find your home state's EMS office (OEMS) in order to request verification. This verification is required to submit as part of your application for Massachusetts EMT licensure. Below you will find information on requesting verification from your home state and applying for national EMT certification.

If you have any questions during this process, please do not hesitate to email us for assistance.

Send the following information to your home state's EMS office to request verification:

You must be nationally certified prior to applying for your Massachusetts EMT license through NREMT. The steps are outlined on the the NREMT website on the Certification Process tab under Application Process.

Refer to the NREMT website for login, complete details on the application process and additional information not provided here.

1. Create an account/login profile.

2. Complete a National Registry application and including the Licensing Action and criminal statements.

3. Pay the application fee as noted on the NREMT website. This fee is charged for each attempt of the cognitive examination.

4. Mail the filled-out Verification of Emergency Medical Technician Status form to NREMT with a self-addressed stamped envelope to National Registry of Emergency Medical Technicians, 6610 Busch Boulevard, Columbus, OH 43229. Be sure to complete this step as it is not detailed on the NREMT website.

5. Candidates will receive an electronic Authorization to Test (ATT) once you are eligible for the exam. The electronic ATT contains scheduling instructions for the cognitive test and important details concerning proper identification required at testing centers.

Exception:

• If you do not have your NREMT certification because you completed your EMT class prior to turning 18, you may be able to transfer your cognitive test results without repeating the exam. You must have already created an NREMT account and be certified in a state that utilizes the NREMT cognitive and practical exam. Contact your state OEMS to confirm that the following is an option for you.

• Login and create a new National Registry application. Ensure that your training center has Verified your course and test results. If you have already paid the required application fee, you will not have to pay this again, however you must pay a processing fee.

• Send a letter to National Registry of Emergency Medical Technicians, 6610 Busch Boulevard, Columbus, OH 43229, explaining that you would like to transfer your examination results (sample letter requesting transfer of examination results).

• Your NREMT account will be updated stating that you have successfully earned your national EMS certification. This typically occurs within 7-10 business days.

Next Step

Once you have received verification through your home state and are nationally certified, you can apply for a Massachusetts EMT license through the mail or online.

Gujarat: The Director of Medical Education (DME Gujarat) has released the schedule for the reporting process for round 3 of CPS Diploma courses. The rank-wise result, list of candidates required to report to the help center, and vacant seats after exhaustion of the merit list have also been released.

The selected candidates can pay the fee online or at a designated branch of Axis Bank up to 3.30 pm on 5th January 2024. The last date to report to the help center is 6th January 2024 up to 12:00 pm. Help center working hours from 10.00 am to 4.00 pm (on working days only). Offline payment of fees at a designated branch of Axis Bank can be done during Banking hours on working days only.

The candidate has to pay Tuition Fees for one term (6 months) by Cash OR Demand Draft in favor of ACPUGMEC payable at Gandhinagar.

At present, this DD is not required to be submitted at the help center of the Admission committee. After completion of the admission process, whenever CPS, Mumbai informs you of the enrollment process of CPS, Admission, at that time only you have to submit this DD to an authorized person of CPS Mumbai directly.

The candidate has to take an appointment at the nearest help center. After taking the appointment, the candidate can download his allotment letter and fees challan from his account after login with the help of User ID & Password.

The tuition fees of CPS Diploma Courses - 6 Lakh/Year for Merit Quota Seats and 12 to 18 Lakh/Year for Institutional Quota Seats in private institutions.

The candidates have to submit their original documents as follows -

1. Allotment Letter of ACPPGME

2. Tuition Fees Receipt

3. All-year MBBS mark sheets

4. 12 months internship completion certificate (Must be completed on or before Dt.11/08/2023)

5. Copy of NEET-PG-2023 Marksheet

6. Document showing Place of birth and date of Birth & Indian Citizenship (School leaving Certificate Transfer Certificate/ Passport/ Birth Certificate

7. Provisional Registration of State Medical Council OR Medical Council of India (In case of fresh candidates only who have just completed their internship)/Permanent Registration of S Medical Council OR Medical Council of India (In case of old pass-out candidates

8. For SEBC, ST, and SC Category: Caste certificate issued by Competent Authorities of Gujarat State only

9. For SEBC Category: Non-creamy layer certificate (Parishistha ‘4’ in Gujarati/English) issued by Competent Authorities of Gujarat State only as per Govt. norms issued after Dt: 01/04/2021

10. For EWS (Economically Weaker Sections) Category: EWS certificate issued by Competent Authorities Gujarat State only issued after Dt: 01/04/2021

11. Copy of Passport- If Citizenship is Dual/ Foreign

12. 12th Marksheet (For candidates who have done MBBS outside Gujarat

13. Domicile certificate of Gujarat state: For candidates who have done MBBS outside Gujarat& only if birthplace is outside Gujarat

14. Photo Copy of Disability Certificate issued by a Competent Authority (For PwD Candidates)

Failing to bring any original documents, the candidate will have no right of admission.

Vacant seat after round 3 –

A total of 29 seats are vacant after round 3.

Detailed seat matrix –

Diseases, Conditions, Syndromes

The chikungunya virus is widespread in tropical regions, where it is spread to humans by mosquitoes of the genus Aedes. Chikungunya is characterized by high fever, headache, muscle and joint pain, rash, and sometimes diarrhea. ...

Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise degenerating and diseased cornea by providing protection against cell death and promoting cell regeneration.

Due to a lack of currently available medical therapy, patients suffering from corneal endothelial disease, which leads to corneal swelling and potentially blindness, commonly require corneal transplantation. In fact, corneal transplantation is the most common type of transplant performed.

There is an urgent unmet need for safe and effective medical strategies for the prevention and reversal of persistent corneal edema, according to the investigators at Mass Eye and Ear of the Harvard Medical School Department of Ophthalmology. Therefore, there is a pressing need for the development of efficacious treatment for preventing, and potentially reversing, corneal edema due to corneal endothelial cell (CenC) loss following corneal injury.

This study examined the effect of local administration of α-MSH on persistent corneal edema and endothelial regeneration in an established model of injury-induced endothelial decompensation. The results show the impressive therapeutic potential of promoting the melanocortin pathway using α-MSH, thus opening new avenues of therapy.

Lead investigator Reza Dana, MD, MSc, MPH, Director of the Cornea and Refractive Surgery Service at Mass Eye and Ear, and Claes H. Dohlman Professor of Ophthalmology at Harvard Medical School, explains, "Our data, demonstrating the potent therapeutic effects of α-MSH through melanocortin receptor agonism, provide compelling evidence for the therapeutic potential of this pathway for a wide array of ocular disorders such as Fuchs Dystrophy, a common disease and indication for corneal transplantation, as well as other disorders of the corneal endothelium that lead to corneal swelling."

α-MSH is an evolutionarily conserved neuropeptide derived from the proteolysis of the pro-opiomelanocortin and exerts an array of functions through different melanocortin receptors expressed in various tissues. Findings in this seminal study show that administration of α-MSH:

• Prevents corneal endothelial cell death
• Restores normal endothelial function
• Permits the cornea to resume normal thickness after a severe injury that normally leads to corneal thickening
• Causes corneal cells to regenerate

Interventions to prevent corneal edema following ocular injury are currently limited to topical hypertonic saline and topical anti-inflammatory drugs. However, these interventions have limited efficacy, and they do not prevent CEnC decompensation.

Dr. Dana concludes: "The findings of their study suggest the therapeutic potential of α-MSH, or analogs that work by activating the melanocortin receptor system, in management of pathologies where there is a risk of corneal endothelial dysfunction, such as corneal injury or intraocular surgery. This study outlines the critical role played by neuropeptides in CEnC maintenance and offers a novel perspective on their potential application in corneal endothelial regeneration."